α-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation

Experimental Hematology

Volumn 25, Issue 9, 1997, Pages 935-944

  Inoue, H ^a   Koezuka, Y ^a   Nishi, N ^a   Osawa, M ^a   Motoki, K ^a   Kobayashi, E ^a   Kabaya, K ^a   Obuchi, M ^a   Fukushima, H ^a   Mori, K J ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

Agelasphins; Cytokines; Radioprotection E CFU S

Indexed keywords

AGL 517; ALPHA GALACTOSYLCERAMIDE; CERAMIDE DERIVATIVE; FLUOROURACIL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 6; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CELL PROTECTION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; SURVIVAL TIME;

ANIMALS; GALACTOSYLCERAMIDES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; INTERLEUKIN-3; INTERLEUKIN-6; KINETICS; MALE; MICE; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RECOMBINANT PROTEINS; STEM CELL FACTOR; SURVIVAL RATE; WHOLE-BODY IRRADIATION;

AGELAS; ANIMALIA; MURINAE;

EID: 0030816470     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)